# Alternative Treatment Paradigm for Natalizumab Trial

> **NCT01710228** · PHASE2 · WITHDRAWN · sponsor: **University of Texas Southwestern Medical Center**

## Conditions studied

- Multiple Sclerosis (MS)

## Interventions

- **DRUG:** methylprednisolone

## Key facts

- **NCT ID:** NCT01710228
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-07
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** sponsor stopped
- **Last updated:** 2016-12-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01710228

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01710228, "Alternative Treatment Paradigm for Natalizumab Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01710228. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*